The Bulletin
Men's Weekly


.

Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand

  • Written by PR Newswire
Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand

INDIANAPOLIS, Nov. 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces Illuccix® (kit for the preparation of gallium Ga 68 gozetotide injection) with up to 50mCi for radiolabeling is available for use on 100mCi (millicurie) gallium generators, an important development in radioisotope production....